Aureus Asset Management, LLC Bristol Myers Squibb CO Transaction History
Aureus Asset Management, LLC
- $1.51 Billion
- Q3 2025
A detailed history of Aureus Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aureus Asset Management, LLC holds 19,686 shares of BMY stock, worth $921,501. This represents 0.06% of its overall portfolio holdings.
Number of Shares
19,686
Previous 54,070
63.59%
Holding current value
$921,501
Previous $2.5 Million
64.55%
% of portfolio
0.06%
Previous 0.16%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,684Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...